New Worm-Fighting pill could help millions of children
NCT ID NCT06128447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests a chewable tablet called ZP5-9676 (flubendazole) against common intestinal worms like hookworm, roundworm, and whipworm. About 300 people aged 6 months to 59 years from high-risk areas will receive either the drug or a placebo. The goal is to see if the drug can cure the infection and reduce egg counts in stool.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ZP5-9676 (flubendazole) chewable tablet
What this could lead to
If successful, this could provide a new, effective treatment for common intestinal worm infections, improving health in affected communities.
What could go wrong
This is a placebo-controlled trial, so some participants may not receive active treatment. Results may vary by worm type, and long-term effectiveness is not yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOIL-TRANSMITTED HELMINTHIASIS (STH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clínica de Vacinas
RECRUITINGAmericaninha, Brazil
Contact